Month: April 2023

ROSEN A LEADING AND RANKED FIRM, Encourages BurgerFi International, Inc. f/k/a Opes Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BFI, OPES

Asianet Pakistan

NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BurgerFi International, Inc. f/k/a Opes Acquisition Corp. (NASDAQ: BFI, OPES) between December 17, 2020 and November 15, 2022, both dates inclusive (the “Class Period”), of the important June 5, 2023 lead plaintiff deadline. SO WHAT: If […]

Read More

Beer and Beats: Victoria™ Partners with Leading Mexican Band Grupo Firme for 2023 United States Tour

Asianet Pakistan

Traditional Mexican beer brand offers fans the chance to connect with Grupo Firme via all-access concert trip, prize packs Grupo Firme and Victoria CHICAGO, April 21, 2023 (GLOBE NEWSWIRE) — Considered Mexico’s oldest beer brand, VictoriaTM has announced a new partnership with Grupo Firme, one of the most popular acts in Latin music today. As presenting […]

Read More

Publication Relating to Transparency Notifications

Asianet Pakistan

 REGULATED INFOMATION Publication Relating to Transparency Notifications Mont-Saint-Guibert (Belgium), April 20, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Together Partnership On April 18, […]

Read More

Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study

Asianet Pakistan

Perioperative toripalimab plus chemotherapy significantly improved EFS and reduced risk of disease recurrence, progression events or death by 60% among resectable stage III NSCLC patients, compared to chemotherapy alone Results from the Neotorch study were presented during the ASCO April Plenary Series SHANGHAI, China, April 20, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd […]

Read More